These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 1350488
1. The role of alpha- and beta-adrenoceptor blockade in antihypertensive treatment. van Zwieten PA. Clin Investig; 1992; 70 Suppl 1():S7-12. PubMed ID: 1350488 [Abstract] [Full Text] [Related]
5. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Nichols AJ, Gellai M, Ruffolo RR. Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335 [Abstract] [Full Text] [Related]
7. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol. Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF. Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930 [Abstract] [Full Text] [Related]
8. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol. Kubo T, Azevedo ER, Newton GE, Parker JD, Floras JS. J Am Coll Cardiol; 2001 Nov 01; 38(5):1463-9. PubMed ID: 11691524 [Abstract] [Full Text] [Related]
9. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension]. Perocchio M, Gigli G, Barra M, Sacchetti R, Vallebona A, Rosolen GA, Orlandi S. Minerva Cardioangiol; 1996 Mar 01; 44(3):115-21. PubMed ID: 8767610 [Abstract] [Full Text] [Related]
11. Carvedilol and the kidney. Dupont AG. Clin Investig; 1992 Mar 01; 70 Suppl 1():S127-31. PubMed ID: 1350479 [Abstract] [Full Text] [Related]
12. Vasodilatory action of carvedilol. Sponer G, Strein K, Bartsch W, Müller-Beckmann B. J Cardiovasc Pharmacol; 1992 Mar 01; 19 Suppl 1():S5-11. PubMed ID: 1378150 [Abstract] [Full Text] [Related]
13. Vasodilators in hypertension--a review with special emphasis on the combined use of vasodilators and beta-adrenoceptor blockers. Eggertsen R, Hansson L. Int J Clin Pharmacol Ther Toxicol; 1985 Aug 01; 23(8):411-23. PubMed ID: 2864319 [Abstract] [Full Text] [Related]
14. Use of carvedilol in hypertension: an update. Leonetti G, Egan CG. Vasc Health Risk Manag; 2012 Aug 01; 8():307-22. PubMed ID: 22661898 [Abstract] [Full Text] [Related]
15. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats. Inagaki O, Sudoh K, Shibasaki M, Nakagawa C, Honda K. J Cardiovasc Pharmacol; 1994 Nov 01; 24(5):794-802. PubMed ID: 7532758 [Abstract] [Full Text] [Related]
16. [Evaluation of the antihypertensive drugs carvedilol, doxazosin and moxonidine]. Dominiak P. Wien Med Wochenschr; 1995 Nov 01; 145(15-16):373-82. PubMed ID: 7502518 [Abstract] [Full Text] [Related]
17. Antihypertensive profile of carvedilol. Meyer-Sabellek W, Agrawal B. Clin Investig; 1992 Nov 01; 70 Suppl 1():S43-52. PubMed ID: 1350484 [Abstract] [Full Text] [Related]
18. Metabolic effects of carvedilol in hypertensive patients. Lithell H, Andersson PE. Eur J Clin Pharmacol; 1997 Nov 01; 52(1):13-7. PubMed ID: 9143861 [Abstract] [Full Text] [Related]